Analyst Reco. Pfizer Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 12:39:38 2025-12-16 pm EST			5-day change	1st Jan Change
25.20 ^USD	-4.67%		-0.95%	-5.43%

12:17pm	Wall St slips on losses in healthcare stocks, focus on 'distorted' economic data	RE
12:09pm	Top Midday Stories: Pfizer Falls Following 2026 Outlook; Netflix-iHeartMedia Exclusive Deal; Apple's Possible iPhone Lineup Expansion	MT

Analyst Reco.

PFIZER INC : JP Morgan is Neutral	09:43am	ZD
Morgan Stanley Adjusts Price Target on Pfizer to $28 From $32, Maintains Equalweight Rating	Dec. 12	MT
PFIZER INC : JP Morgan remains Neutral	Dec. 10	ZD
HSBC Adjusts Price Target on Pfizer to $29 From $28, Maintains Buy Rating	Dec. 10	MT
PFIZER INC : Berenberg reaffirms its Neutral rating	Nov. 26	ZD
Guggenheim Adjusts Price Target on Pfizer to $35 From $33, Maintains Buy Rating	Nov. 24	MT
Daiwa Securities Adjusts Price Target on Pfizer to $27 From $29, Maintains Outperform Rating	Nov. 17	MT
Rothschild & Co Redburn Adjusts Price Target on Pfizer to $24 From $25, Maintains Neutral Rating	Nov. 14	MT
BioNTech Says Collaboration With Pfizer Unchanged	Nov. 13	MT
Scotiabank Initiates Pfizer at Sector Outperform With $30 Price Target	Nov. 13	MT
Sector Update: Health Care Stocks Advance Late Afternoon	Nov. 10	MT
Pfizer CEO Albert Bourla says Think Co will pay entire CVR for Metsera - CNBC interview	Nov. 10	RE
CMB International Initiates Pfizer at Buy With $36.16 Price Target	Nov. 10	MT
Pfizer to Acquire Metsera Under Amended Deal; Novo Nordisk Says No Plan to Increase Offer for Metsera	Nov. 10	MT
PFIZER INC : Gets a Neutral rating from JP Morgan	Nov. 10	ZD
Pfizer wins tug-of-war over Metsera after raising its bid	Nov. 10	FW
Metsera says Pfizer to buy Metsera for up to $86.25 per share	Nov. 07	RE
Pfizer sweetens its offer for Metsera in bidding war against Novo - Bloomberg news	Nov. 07	RE
America's markets lose their nerve	Nov. 07
Novo Nordisk again raises bid in takeover fight for Metsera - FT	Nov. 06	RE
Pfizer submitted its sweetened bid to buy Metsera, which matches Novo's offer valuing Metsera at $86.20 a share - FT	Nov. 05	RE
Pfizer is making plans to deliver fresh bid for Metsera on Wednesday - WSJ	Nov. 05	RE
PFIZER : Jefferies still a buyer after Q3 results	Nov. 05
Goldman Sachs Adjusts Price Target on Pfizer to $26 From $27, Maintains Neutral Rating	Nov. 05	MT
Obesity Category Still Hot: Mizuho's Jared Holz	Nov. 05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle

November 04, 2025 at 01:28 pm EST

Pfizer, Inc. under full-scale attack

October 08, 2024 at 06:16 am EDT